Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant for insomnia with comorbid nocturia
2022-501246-30-00Phase 4Completed
- Sponsor
- Idorsia
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, randomised, double-blind trial of daridorexant in Insomnia and nocturia (2 arms), sponsored by Idorsia. Primary endpoint: Change from baseline to Week 4 in subjective total sleep time (sTST). Started Mar 2023; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnianocturia
Beyond the preview
Go deeper on 2022-501246-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501246-30-00.